158 related articles for article (PubMed ID: 2112582)
1. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
[TBL] [Abstract][Full Text] [Related]
2. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Shaw RW; Matta W
Clin Reprod Fertil; 1986 Oct; 4(5):329-36. PubMed ID: 3100012
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant)].
Nisolle M; Clerckx F; Casanas-Roux F; Gillerot S; Bourgonjon D; Donnez J
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):759-63. PubMed ID: 2124231
[TBL] [Abstract][Full Text] [Related]
5. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
Mizutani T; Sakata M; Terakawa N
Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
[TBL] [Abstract][Full Text] [Related]
6. Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis.
Donnez J; Nisolle-Pochet M; Clerckx-Braun F; Sandow J; Casanas-Roux F
Fertil Steril; 1989 Jul; 52(1):27-30. PubMed ID: 2501110
[TBL] [Abstract][Full Text] [Related]
7. CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
Negri P; Ricciardelli MA; Tomasi A; Grechi E; Fortini RM
Acta Eur Fertil; 1992; 23(4):171-4. PubMed ID: 1343472
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal changes in buserelin therapy].
Fuchs U; Zwirner M
Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
[TBL] [Abstract][Full Text] [Related]
9. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
11. [Blood levels of gonadotropic and steroid hormones in patients with internal endometriosis treated by transcerebral ultrahigh frequency electromagnetic fields].
Perfil'eva IF; Chel'tsova NV; Tashlitskaia MI; Korovkina EG
Vopr Kurortol Fizioter Lech Fiz Kult; 1988; (3):66-8. PubMed ID: 3212969
[No Abstract] [Full Text] [Related]
12. [Buserelin--a GnRh analog for the treatment of endometriosis].
Litschgi M
Schweiz Rundsch Med Prax; 1989 Apr; 78(14):399-402. PubMed ID: 2524870
[TBL] [Abstract][Full Text] [Related]
13. GnRH analogues in the treatment of endometriosis.
Erickson LD; Ory SJ
Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
[TBL] [Abstract][Full Text] [Related]
15. Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
Marana R; Muzii L; Muscatello P; Lanzone A; Caruso A; Dell'Acqua S; Mancuso S
Br J Obstet Gynaecol; 1990 Nov; 97(11):1016-9. PubMed ID: 2147564
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
Lemay A; Maheux R; Jean C; Faure N
Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
[No Abstract] [Full Text] [Related]
17. Efficacy of gonadotropin-releasing hormone agonist (buserelin) in the treatment of endometriosis.
Rönnberg L; Koskimies A; Laatikainen T; Ranta T; Saastamoinen J
Acta Obstet Gynecol Scand; 1989; 68(1):49-53. PubMed ID: 2508418
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Raitz von Frentz M; Schweppe KW
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
[TBL] [Abstract][Full Text] [Related]
19. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Minaguchi H; Uemura T; Shirasu K
Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
[No Abstract] [Full Text] [Related]
20. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
